Is BrainsWay Ltd. (BWAY) a Buy, Sell, or Hold?
NASDAQ : BWAY
BrainsWay Ltd.
$16.5 USD
$0.77 (4.9%)
- Volume
- 323.19K
- Average Volume
- 117.75K
- Market Capitalization
- $647.18M
- P/E Ratio
- 73.82
- Dividend Yield
- 0.00%
- Price Target
- $15.00
- Year High
- $17.35
- Year Low
- $5.68
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $3.34
Company Overview
NASDAQ
Hadar Levy
Medical - Devices
Healthcare
BWAY
129
IL
USD
Liquidity Metrics
0.09
3.34
3.04
2.49
0.00
Sales & Valuation
$52.22M
11.03
8.37
59.58
0.59
Profitability
$0.36
$7.63M
14.57%
15.68%
12.28%
7.54%
P/E Metrics
73.82
0.81
0.81
Analyst Price Target & Rating
$15.00
$18.00
$14.00
3/5
6 Analysts
10.00%
Financial Health Scores
9.28
6/9
$55.07M
$117M
$41.2M
$10.96M
Key Metrics (TTM)
$614.98M
10.16
84.31
3.34
12.28%
6.43%
1.39%
1.68%
$3.21
148 days
Company Executives
| Name | Title |
|---|---|
| Hadar Levy | Chief Executive Officer |
| Abraham Zangen | Co-Founder, Member of Scientific Advisory Board & Director |
| Michael Cohen | Vice President of US Sales |
| Dor Hagai | Vice President of Operations |
| Menachem C. Klein | Vice President, General Counsel & Corporate Secretary |
| Gilead Moiseyev | Chief Technology Officer |
| Yiftach Roth | Founder & Chief Scientific Officer |
| David Zacut | Co-Founder & Vice-Chairman |
| Ido Marom | Chief Financial Officer |
| Colleen Hanlon | Vice President of Medical Affairs |
Poll Results
No votes yet today — be the first to share your view!
About BrainsWay Ltd. (NASDAQ:BWAY) Stock
BrainsWay Ltd. develops and distributes non-invasive neurostimulation therapies that address a broad spectrum of mental health and neurological conditions. The company operates globally, with a presence in the United States, Europe, and Israel, among other international markets. Its primary offering is the Deep Transcranial Magnetic Stimulation (dTMS) platform technology, which provides treatment for various ailments including major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post-traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post-stroke rehabilitation, and Parkinson's disease. BrainsWay's clientele primarily comprises medical professionals, hospitals, and medical ... centers specializing in psychiatry. The company was founded in 2003 and is headquartered in Jerusalem, Israel.
4 Medical Products Stocks Poised to Win Despite Industry Headwinds
2026-07-20 15:15:53
Terumo, QuidelOrtho, Lumexa Imaging and BrainsWay are tackling industry headwinds through innovation, pricing and execution as healthcare demand stays resilient.
BrainsWay Announces Strategic Investment in Radial Health, Inc.
2026-07-20 07:30:00
BrainsWay continues to actively evaluate similar investments in leading North American mental health providers to raise awareness and expand access to transformative care BrainsWay continues to actively evaluate similar investments in leading North American mental health providers to raise awareness and expand access to transformative care
BrainsWay Announces Minority-Stake Investment in Sound Minds Behavioral
2026-07-16 07:30:00
Investment further supports BrainsWay's strategy of partnering with growth-oriented mental health providers to raise awareness and expand access to transformative care Investment further supports BrainsWay's strategy of partnering with growth-oriented mental health providers to raise awareness and expand access to transformative care
Best Momentum Stocks to Buy for July 14th
2026-07-14 11:01:20
BWAY, HTLD and NCNO made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on July 14th, 2026.
New Strong Buy Stocks for July 14th
2026-07-14 08:46:08
HTLD, MEOH, NCNO, JD and BWAY have been added to the Zacks Rank #1 (Strong Buy) List on July 14th, 2026.
2026-06-29 07:30:00
Nearly half of individuals diagnosed with PTSD also meet criteria for major depressive disorder (MDD), making comorbid depression one of the most common and clinically significant complications of PTSD
2026-06-22 07:30:00
BURLINGTON, Mass. and JERUSALEM, June 22, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive brain stimulation technologies, today announced further expansion in the number of medical policies across the U.S. providing favorable coverage for its SWIFT™ Accelerated Deep TMS™ protocol. The announcement comes after a series of favorable policy changes, the latest of which is a recently issued policy covering 2 million members in South Carolina allowing for coverage of SWIFT, in addition to various other increases in Deep TMS coverage for both major depressive disorder (MDD) and obsessive-compulsive disorder (OCD) patients.
2026-06-09 07:30:00
Preliminary Data Analysis Reveals Over 80% Remission Rate One Year after Accelerated Deep TMS Treatment, with Decline in Severe Functional Impairment from 85% to 0% Preliminary Data Analysis Reveals Over 80% Remission Rate One Year after Accelerated Deep TMS Treatment, with Decline in Severe Functional Impairment from 85% to 0%
Frequently Asked Questions
-
What is the current BrainsWay Ltd. (BWAY) stock price?
-
BrainsWay Ltd.(NASDAQ:BWAY) stock price is $16.5 in the last trading session. During the trading session, BWAY stock reached the peak price of $17.352 while $5.6765 was the lowest point it dropped to. The percentage change in BWAY stock occurred in the recent session was 4.9% while the dollar amount for the price change in BWAY stock was $0.77.
-
BWAY's industry and sector of operation?
-
The NASDAQ listed BWAY is part of Medical - Devices industry that operates in the broader Healthcare sector.
-
Who are the executives of BWAY?
-
Hadar Levy | Chief Executive Officer
Abraham Zangen | Co-Founder, Member of Scientific Advisory Board & Director
Michael Cohen | Vice President of US Sales
Dor Hagai | Vice President of Operations
Menachem C. Klein | Vice President, General Counsel & Corporate Secretary -
How many employees does BWAY have?
-
Number of BWAY employees currently stands at 129. BWAY operates from Bynet Building, Jerusalem, JM 9777518, IL.
-
Link for BWAY official website?
-
Official Website of BWAY is: https://www.brainsway.com
-
How do I contact BWAY?
-
BWAY could be contacted at phone #972 2 582 4030 and can also be accessed through its website. BWAY operates from Bynet Building, Jerusalem, JM 9777518, IL.
-
How many shares of BWAY are traded daily?
-
The average number of BWAY shares traded daily for last 3 months was 117.75K.
-
What is the market cap of BWAY currently?
-
The market value of BWAY currently stands at $647.18M with its latest stock price at $16.5